MLSS · Milestone Scientific Inc.
$0.36
-0.05 (-11.98%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred recurring operating losses and has an accumulated deficit. These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Management believes that existing cash resources, anticipated collections and potential financing proceeds may support near-term operations; however, additional financing is required, and there can be no assurance that such financing will be available on acceptable terms, or at all. Accordingly, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”View the 10-Q filed Aug 13, 2026
Market Cap
$36.45M
Shares
88.74M
Volume · Oct 1
14.13K
Avg daily vol (3M)
124.04K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.41
Open$0.41
Day$0.40–0.41
52W close$0.25–0.55
Avg vol 30d78K
Short int91K · 0.1% float · 1.3d
Short vol2%
Last earningsMar 31, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 13
Up next
filed Aug 13, 2026
call held Mar 31, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-10.9%
Trailing year
Short interest
0.1%
Latest settlement · 1.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.4 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+16%
above
Price vs 50-day avg
−8%
below
RSI (14)
44
neutral
MACD trend
Positive
52-week position
53%
mid-range
Momentum
relative strength
1-month return
−11%
trailing
6-month return
+46%
trailing
YTD return
+51%
this year
Relative strength
+34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Distributing
-9% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.10% of float · ▲ +16.2% MoM · 1.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
29 holders — near 3-yr low, contrarian setup
Squeeze score
39
low risk · 0–100
Fundamentals
Revenue growth
+4%
Y/Y
Gross margin
71%
contracting
EPS growth
−17%
Y/Y
Free cash flow
$-2.9M
Quant / Vol
risk profile
Volatility
83%
annualized · 1-yr
Max drawdown
−54%
past year
ATR
7.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2026
Total revenue
· 2026
$9.8M – $10.2M
prior FY $8.97M
midpoint +11.4% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+16%
Bullish
Price vs 50-day avg
−8%
Bearish
RSI (14)
44
Neutral
MACD trend
Positive
Bullish
52-week position
53%
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow
Distributing
-9% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.10% of float · ▲ +16.2% MoM · 1.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
29 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $0 · 53%
Range high $1
vs 200-day avg +16%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MLSS
this stock
Milestone Scientific Inc.
|
$36.45M | +51.5% | +4.0% | — | 0.1% |
|
ISRG
Intuitive Surgical Inc
|
$143.14B | -29.2% | +20.5% | 46.5 | 2.3% |
|
BDX
Becton Dickinson & Co
|
$49.57B | — | +8.2% | — | 4.2% |
|
MDLN
Medline Inc.
|
$45.62B | -16.8% | +11.5% | — | 3.1% |
|
RMD
Resmed Inc
|
$32.02B | -8.2% | +13.4% | 21.3 | 9.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MLSS | -0.4% | -11.1% | +46.1% | +2.0% | +51.5% |
| SPY | -0.4% | -0.2% | +12.4% | +0.2% | +12.0% |
| vs SPY | +0.0% | -10.9% | +33.6% | +1.8% | +39.4% |